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Novel mesoporous silica nanoparticles (LPMSN) functionalied with degradable poly(2-
dimethylaminoethyl acrylate) (PDMAEA) have been developed (PDMAEA-LPMSN) as nano-carriers for 
gene delivery. The unique design of PDMAEA-LPMSN has endowed this system with multifunctions 
derived from both the organic and inorganic moieties. The cationic polymer unit binds to genetic 10 
molecules and undergoes a self-catalyzed hydrolysis in water to form a non-toxic anionic polymer 
poly(acrylic acid), allowing controlled release of siRNA in the cells. The nanopores of LPMSN provide a 
reservoir for storage and release of chloroquine to facilitate endosome escape. The PDMAEA-LPMSN 
composites were characterized by elemental analysis (EA), X-ray photoelectron spectroscopy (XPS), 
solid-state 13C magic-angle spinning nuclear magnetic resonance (MAS-NMR), thermogravimetric 15 
analysis (TGA), and nitrogen sorption techniques. Their siRNA delivery performance was tested in a 
KHOS cell line, showing promising potential for the co-delivery of genes and drugs. 
Introduction 
Small interfering RNA (siRNA) based therapeutics has received 
increasing attention for cancer treatment applications.1 The 20 
siRNA therapy features highly specific siRNA to silence 
oncogenes. However, the vulnerability of siRNA against nuclease 
and the poor cellular delivery hampers its in vivo application.2 
Nanocarriers that can package, protect and deliver siRNA to the 
targeted site hold promise to solve these problems for the 25 
practical applications of siRNA therapy.3 
 Various nanocarriers have been developed to deliver siRNA, 
such as lipid and polymer based carriers.4 Inorganic materials 
(e.g. gold, iron oxide and silica materials) have also been studied 
as carriers for genetic molecules.5-8 Recently, mesoporous silica 30 
nanoparticles (MSN) based materials showed promising 
performance as gene carriers. 9-11 Various surface modified MSN 
have been systematically studied to deliver siRNA. Short amine 
silane moieties have been extensively used to increase silica 
affinity towards the nucleic acid agents (DNA, siRNA).9-11  Meng 35 
et al used polyethyleneimine (PEI) modified MSN with different 
molecular weights to enhance the efficacy of siRNA.12 In 
addition, polyamine dendrimer-MSN have also been used for 
delivering siRNA.13 Composite materials consisting of both 
polymer and mesoporous silica combine the benefits from each 40 
component to create a more advanced carrier system.8, 13, 14 
Polycation or polyamine complex with MSN are more versatile 
compared to the short chain amine-MSN. The presence of multi 
amine moieties significantly enhances particle affinity towards 
siRNA and cell membrane. 15 45 
 The main issue related to the polycation complex with siRNA 
(polyplex) is the strong binding between the abundant positive 
charge on the polymer and the negatively charged phosphonic 
acid of the nucleic acid, which hinders the release of siRNA 
within cytoplasma thus lowering the efficacy of siRNA.16, 17 This 50 
factor is also known as vector unpacking. To exert siRNA 
function, it needs to be transferred into cytoplasm and released 
from the carrier as free molecules to induce gene silencing.18, 19 
The second issue is cytotoxicity of polycation.17 This condition 
raises a concern about accumulated toxicity of the nanoparticles, 55 
especially after multi-administration. Previously, we have 
reported the use of poly-l-lysine (PLL) functionalised large pore 
mesoporous silica nanoparticles (LPMSN-P) as gene carriers.15 
PLL-functionalized nanoparticles had a strong binding towards 
nucleic acid molecules and delivered oligo DNA-Cy3 (a model 60 
for siRNA) efficiently to HeLa cells. However, the low release of 
siRNA from the complex limited the effectiveness of this system. 
 Degradable polycationic polymers that can be degraded into 
non-toxic compounds and enhance gene release are preferable as 
carriers in gene therapy.16 Several methods have been used to 65 
establish degradable structures by introducing cleavable bonds 
into the polymer structures. The cleavable bonds include esters, 
amides, carbonates and disulfides. Most of these structures 
depend on various external triggers (pH, redox potential and 
enzymes) to start the degradation.17, 20-22 Yet, the high fluctuation 70 
of these triggers within the human body might cause 
 
inconsistency in the cleavage reactions, resulting in variable and 
unpredictable rates of degradation.23, 24 It is desirable to use a 
cleavable polymer that degrades only after being internalized by 
target cells in a simple and controlled manner.23, 24 
 Recently, a self-catalyzed degradable cationic polymer 5 
(poly(2-dimethylaminoethyl acrylate), PDMAEA), which 
degrades independently of an external degradation trigger, has 
been developed. 23, 24,25 The degradation product is the non-toxic 
poly(acrylic acid), PAA. The most prominent features of this 
polymer are the ability to bind and protect oligo-DNA for 10 
sufficient times and the capacity to release the DNA inside the 
cells after 10 hours.23, 24,25 In this work, we used PDMAEA 
covalently attached to the surface of large pore mesoporous silica 
nanoparticles (PDMAEA-LPMSN) to act as a dual delivery 
system. The surface bound PDMAEA can bind and release 15 
siRNA 'on-demand'. Chloroquine was loaded in the nanopores of 
LPMSN as a model drug which helps endosome escape. It was 
shown that PDMAEA-LPMSN released oligo-DNA (mimicking 
siRNA) within 2 days of incubation, while little release was 
observed in polyethyleneimine (PEI) functionalized LPMSN. In 20 
the delivery of a functional siRNA (PLK1), chloroquine loaded 
PDMAEA-LPMSN inhibited the viability of KHOS cancer cells 
significantly compared to PDMAEA-LPMSN, showing the 
advantage of a carefully designed composite co-delivery system. 
Experimental section 25 
Chemicals  
Triblock poly(ethylene oxide)-b-poly(propylene oxide)-b-poly 
(ethylene oxide) copolymer EO106PO70EO106 (Pluronic F127, 
MW=13400), fluorocarbon surfactants (FC-4), tetraethoxysilane 
(TEOS, 99%), 1,3,5-trimethylbenzene (TMB), Copper(I) bromide 30 
,3-glycidoxypropyl trimethoxysilane (3-GPS), 3-
aminopropyltriethoxysilane (APTES, 99%), sodium azide, ethyl 
2-chloropropionate (97%), copper powder (size <425 µm, 99.5% 
trace metals basis), tris[2-(dimethylamino)ethyl]amine were used  
as received from Sigma Aldrich. 2-(dimethylamino) ethyl 35 
acrylate (98%), N,N-Dimethylacrylamide (99%) were passed 
through a column of basic alumina to remove inhibitor before 
use. N-hexane (>98%), dichloromethane (99.8%), and methanol 
(99.8%) were used as received from Merck. Polyethyleneimine 
(PEI) (MW: 10 kDa) were purchased from Alfa Aesar (Ward 40 
Hill, MA). All chemicals were used as received without 
purification. Cell lines used: osteosarcoma cell line KHOS/NP 
(CRL-1544™) were purchased from ATCC (American Type 
Culture Collection). Twenty-one-nucleotide (oligo) DNA 
conjugated with cyanine dye (Cy-3), fetal calf serum, 45 
paraformaldehyde and anti-fade fluorescent mounting medium 
with 4'-6-Diamidino-2-phenylindole (DAPI) were purchased 
from Sigma Aldrich. Dulbecco's Modified Eagle's Medium 
(DMEM) and Penicillin G, streptomycin sulphate and L-
Glutamine mixture were from Gibco-Invitrogen. CellTiter-Glo® 50 
cell viability assay kit was from Promega. Synthetic human PLK1 
were purchased from Ambion at Applied Biosystems (Foster 
City, CA). The siRNA sequences are: PLK-S: 5’-
CCAUUAACGAGCUGCUUAATT-3’; PLK-AS: 5’-
UUAAGCAGCUCGUUAAUGGTT-3’. S10-siRNA was 55 
synthesized by Proligo (Lismore, Australia) and the sequence: 
S10-S: 5’-GCAACAGUUACUGCGACGUUU-3’; S10-AS: 5’-
ACGUCGCAGUAACUGUUGCUU- 3’.  
Synthesis of LPMSN 
LPMSN were synthesised following a previous method by Ying 60 
et al.26 First, 0.5 g F127 and 1.4 g of FC-4 were dissolved in 60 
ml of 0.02 M HCl and stirred for 24 hours at 60 ºC. 0.4 g of TMB 
was added into the mixture and stirred at a temperature of 30 ºC 
for 6 hours. Then, 3 g of TEOS was added to the solution, and the 
stirring process at 30 ºC was continued for another 24 hours. The 65 
solution was then transferred into autoclaves for the hydrothermal 
treatment. The hydrothermal temperature was at 100 °C for 24 
hours. The sample was denoted as as-synthesized LPMSN (AS-
LPMSN). The surfactant (F-127) was still remained within the 
pores of AS-LPMSN.  70 
Synthesis of 2-bromo-N-(3-(triethoxysilyl)propyl)propan-
amide 
BPB in 50 mL DCM was added dropwise to a cold solution of 
APTS and TEA in 200 mL dry DCM. The solution was stirred for 
30 min at room temperature and the precipitate was filtered off. 75 
The solution was washed with acidic water and dried with 
magnesium sulphate. After filtration the solvent was removed in 
rotovapor. The product was dried under vacuum for 24 hours. 
 
 80 
Synthesis of Azidation of 2-bromo-N-(3-(triethoxysilyl)-
propyl)propanamide or Azide silane 
BPTS was dissolved in dry DMF and NaN3 was added. The 
mixture was stirred for 48 hours at room temperature. The 
solution was then diluted with 200 mL of DCM, washed by water 85 
and concentrated by evaporator. The product was dried under 
vacuum for 24 hours. 
 
 
Synthesis of Poly(2-Dimethylaminoethyl Acrylate) 90 
(PDMAEA) by SET-LRP 27 
CuCl2/Me6TREN (32 mg, 8.8 x 10-5 mol), Me6TREN (61 mg, 2.6 
x 10-4), ethyl 2-chloropropanoate (120 mg, 8.8 x 10-4 mol) and 2-
dimethylaminoethyl acrylate (DMAEA, 18.9g, 0.132 mol) were 
dissolved in isopropanol (10 mL) and the solution was purged 95 
argon for 30 minutes at room temperature. Cu powder (size < 425 
µm) was added under argon flow. After 7 hours of polymerisation 
at room temperature, the solution was diluted by acetone (100 
 
mL) and passed through Al2O3 to remove copper. Acetone was 
removed by the rotavap, and the product was obtained by 
precipitating in a large excess of cold n-hexane (500 mL) and 
then isolated by centrifugation. This procedure was repeated three 
times. The polymer was dried under high vacuum for 48 hours at 5 
room temperature to give a yellow oily product (yield 70%). The 
conversion of polymerization was 40 % as determined by 1H 
NMR spectroscopy. Mn = 4200, PDI = 1.29 (SEC-RI calibrated 
using PSTY standards and used DMAc + 0.03 wt% LiCl as 
eluent). 10 
Synthesis of Azide-MSN (A-MSN), PDMAEA-LPMSN  
To establish azide groups on the surface of LPMSN, 5.3 mg 2-
azido-N-(3-(triethoxy silyl)propyl)propanamide or azide silane 
was grafted onto 100 mg AS-LPMSN in 25 ml Toluene. The 
reaction was maintained at 70 ºC for 24 hours. The product was 15 
washed with toluene and methanol and followed by surfactant 
removal. The surfactant removal was conducted by using an 
extraction process in acidic-methanol for 24 hours and the 
process was repeated three times. The product is named A-MSN. 
A-MSN has an opened pores structure. 20 
Finally, a click reaction between alkynes- poly(2-
dimethylaminoethyl acrylate) (PDMAEA)  and A-MSN also 
known as the Huisgen 1,3-dipolar cyclo-addition can be 
conducted. 100 mg A-MSN and 578 mg PDMAEA was mixed in 
2 ml of toluene at a room temperature under argon, followed by 25 
addition of 9 µl of PMDETA. Then, 6 mg of copper bromide 
(CuBr), as a catalyst, was added to the mixture. The reaction was 
maintained for 24 hours. The product PDMAEA-LPMSN was 
washed and dried in vacuum. 
Synthesis of PEI-LPMSN 30 
At first the epoxysilane was attached on the silica surface: 100 
mg of LPMSN was mixed in 30 ml of toluene and stirred for 15 
minutes at 70 ºC. 1.5 ml of 3-GPS was added into the solution 
and further stirred for 24 hours at the same temperature. The solid 
products (Epoxy-LPMSN) were centrifuged, washed with toluene 35 
and methanol for three times and dried. The next step is to graft 
PEI onto the Epoxy-LPMSN: 80 mg of epoxy modified particles 
were mixed with 200 mg PEI (10 kDa) in 100 ml of carbonate 
buffer (50 mM, pH 9.5) for 24 hours at room temperature. After 
this step, the solid product was produced and washed with 20 ml 40 
of 1.0 M NaCl and water for three times, and then centrifuged. At 
the final stage, the solid products were suspended in 20 ml of 1.0 
M ethanolamine (pH 9) and stirred at room temperature for 6 
hours to block unreacted epoxy groups. The solids were again 
washed with 20 ml of 1.0 M NaCl and 20 mL water. 45 
Adsorption of Chloroquine into PDMAEA-LPMSN 
100 mg of A-MSN was mixed with 80 ml of chloroquine (Chl) 
solution (100 mg/ml). The suspension was incubated for 24 hours 
at room temperature under a constant stirring. Suspension was 
then separated by a centrifugation. Before and after incubation 50 
Chl concentration were determined using UV-vis at a wavelength 
of 329 nm. The difference in Chl amount is determined as the 
amount of Chl absorbed on the material. The adsorption was then 
followed by PDMAEA attachment onto Chl loaded A-MSN. The 
sample is denoted Chl- PDMAEA-LPMSN. 55 
Oligo DNA adsorption and release analysis 
Oligo DNA was complexed with PDMAEA-LPMSN (or PEI-
LPMSN) at 2 different nitrogen to phosphorous ratio (N/P) (N/P 
=1 and 10).  The complex was mixed in 25 µl of water for 30 
minutes at room temperature. Oligo DNA and LPMSN-oligo 60 
DNA were used as controls. Agarose gel retardation assay was 
initiated by adding 5 µl DNA loading dye into the complex which 
then loaded into a 2% agarose gel containing TAE buffer and 
stained with ethidium bromide. The gels were run in 1 x TAE 
buffer for around 10 minutes at 80 V and then followed by 65 
observation under a Bio-Rad UV transiluminator. 
Cytotoxicity test 
The cytotoxicity of PDMAEA-LPMSN and Chl-PDMAEA-
LPMSN in KHOS cells were tested by Cell-Titer Glo assay. 
KHOS cells were seeded in a 96-well cell culture plate with a 70 
density of 5×103 cells/well. After incubation for 24 hours, the 
cells were treated with different concentrations of PDMAEA-
LPMSN and Chl-PDMAEA-LPMSN solution, followed by 
further incubation at 37 °C for 48 hours. The cell viability of 
KHOS cells was evaluated using Cell-Titer Glo assay, according 75 
to the protocol provided by the manufacturer. The cells incubated 
in the absence of particles were used as the control. All the 
experiments were performed in triplicates for each group. The 
statistical data were shown as mean ±(SD). 
Cellular Uptake (Confocal Microscopy)  80 
KHOS cells were maintained in Dulbecco's Modified Eagle 
Medium (DMEM) supplemented with fetal calf serum (10%), L-
glutamine (2%), penicillin (1%), streptomycin (1%) in 5% CO2 
at 37 °C. The medium was routinely changed every 2 days and 
the cells were separated by trypsinisation before reaching 85 
confluency. KHOS cells were seeded in a 6-well plate (1×105 
cells per well) and incubated for 24 hours prior to cell uptake 
assay. 50 µg of PDMAEA-LPMSN or Chl-PDMAEA-LPMSN 
and 2 µl of 100 µM Cy3-oligoDNA was mixed in 100 µl of 
phosphate buffered saline (PBS) solution and incubated at 4°C 90 
overnight. After incubation, the mixture was added to a well of 6-
well plates containing 2.0 ml of serum-free DMEM medium, and 
the final concentration of nanoparticles and Cy3-oligoDNA was 
25µg/ml and 100nM, respectively. After incubation for 4 hours at 
37°C, the cells washed twice with PBS to remove the remaining 95 
nanoparticles, free Cy3-oligoDNA and dead cells. For fixed cell 
imaging, the cells were treated with 500 µl of 4% PFA PBS 
solution for 30 minutes at 4 °C, and their nuclei were stained with 
DAPI for 10 minutes. Finally, the cells were observed under a 
confocal microscope (LSM Zeiss 710).  100 
siRNA function 
To examine whether the particles (PDMAEA-LPMSN and Chl-
PDMAEA-LPMSN) can deliver functional molecules to cells for 
therapy, we chose siRNAs against human PLK1 genes (PLK1-
siRNA). An ineffective siRNA, S10-siRNA, was chosen as a 105 
negative control because S10-siRNA is effective only against 
human papillomavirus (HPV) type E6 gene while there is no 
HPV in KHOS cells. The cells were seeded at 5×103 cells / well 
in 100 µl of complete DMEM medium in 96-well plate and 
culture for overnight before treatment. The siRNAs were 110 
 
absorbed to particles as described above (for 21-nucleotide oligo 
DNA adsorption) and were added to the cells. The cells were 
treated for 48 hours and the silencing effect or cell viability was 
determined by Cell-Titer Glo assay. 
Characterization  5 
Transmission electron microscopy (TEM) images were obtained 
by a JEOL 1010 electron microscope with an acceleration voltage 
100 kV. Scanning electron microscopy (SEM) images were 
recorded on a JEOL 6300 microscope operated at 5-10 kV. 
Nitrogen sorption isotherms of the samples were obtained using a 10 
Quantachrome’s Quadrasorb SI analyser at 77 K. Before the 
measurements, the samples were degassed overnight at 110 °C in 
vacuum. The Brumauer-Emmett-Teller (BET) surface area was 
calculated using experimental points at a relative pressure of P/P0 
= 0.05-0.25. The total pore volume was calculated from the N2 15 
amount adsorbed at the highest P/P0 (P/P0 = 0.99). The pore size 
distribution was calculated by the Broekhoff-de Boer (BdB) 
method using a spherical model. The cavity pore size and 
entrance pore size are determined from the adsorption and 
desorption branches, respectively, using the BdB method. XPS 20 
spectra were recorded on a Kratos Axis Ultra with a 
monochromatic Al Kα X-ray source.  Each spectrum was recorded 
at a survey scan from 0 to 1200 eV with a dwell time of 100 ms, 
pass energy of 160 eV at steps of 1eV with 1 sweep. A high 
resolution scan was conducted at a lower pass energy (20 eV), 25 
higher sweep and dwell time at 250 ms. C1s with a binding 
energy of 285 eV was used as the reference. The atomic ratio of 
LPMSN and their functionalised forms (A-MSN and PDMAEA-
LPMSN) were determined from XPS spectra and elemental 
analysis. Solid state magic-angle spinning (MAS) 13C nuclear 30 
magnetic resonance (NMR) measurements were performed with a 
Bruker MSL-300 spectrometer operating at a frequency of 75.482 
MHz for 13C. The spectrometer was equipped with a 4-mm 
double air bearing, magic angle spinning probe for MAS 
experiments. The proton 90° pulse time used in the CPMAS 35 
method was 5.5 µs, the acquisition time was 45 ms, cross-
polarisation time 2 ms and the relaxation delay was 3 s. The 
spectrum width was 50 kHz, and 4000 data points were collected 
over 2000 scans. Chemical shift of the 13C spectrum was 
referenced to the resonance of adamantine at 38.23 ppm. All 40 
samples were equilibrated at room temperature (22 °C). Zeta 
potential measurements were conducted on a Zetasizer Malvern 
Instrument. TGA/DSC 1 (Mettler-Toledo AG) was used for 
thermogravimetric analysis (TGA) at a heating rate of 2 ºC/min 
under a nitrogen flow of 20 ml/min.  45 
Results and Discussion 
Fig. 1A shows a spherical like morphology of LPMSN with 
particle sizes around 100 – 200 nm. The spherical morphology in 
submicron size can also be confirmed from SEM analysis (Fig. 
2). The nitrogen sorption analysis of LPMSN demonstrates a type 50 
IV isotherm with H2 hysteresis loop at high relative pressure 
indicating the existence of large mesopores with cage-like 
structure (Fig. S1). The cavity size of LPMSN was determined to 
be 11 nm. The main characteristic of LPMSN is its cubic pore 
structure with a high degree of pore interconnectivity allowing 55 
superior mass transfer compared to one-dimensional channel-like 
structures. This structure also makes the nanoparticles more 
resistant to pore blocking. 7, 15  
 PDMAEA (Mn ~ 4200) (Fig. S2A) was attached to LPMSN 
through a linking azide silane agent (250 Da, Fig. S2B). TEM 60 
image of PDMAEA-LPMSN (Fig.1B) reveals that the 
functionalization process does not affect the cubic pore structure. 
The elemental analysis (EA) indicates that there is an increase in 
the atomic percentage of nitrogen (N) after azide attachment to 
1.05 %. The nitrogen content on the surface of LPMSN was also 65 
detected by XPS analysis with an atomic ratio of 1.33% (Table 
1). Similar results are also confirmed after PDMAEA attachment. 
There are significant increases in the C and N percentage after the 
polymer attachment. The carbon composition rose from 6.9% to  
70 
Fig. 1 TEM images of (A) LPMSN and (B) PDMAEA-LPMSN 
(Scale bar: 100 nm) 
 
Fig. 2 SEM image of LPMSN (Scale bar: 1 µm) 
 75 
15.5 % and 13.6% to 59.5% for EA and XPS analysis 
subsequently. On the other hand, nitrogen concentration 
increased to 3.5% and 5.1% for EA and XPS analysis. TGA 
analysis confirms that around 5% weight of azide and 16% 
weight of PDMAEA have been grafted onto LPMSN (Fig. S3). 80 
Table 1. Chemical composition of composite PDMAEA-LPMSN 
 Elemental Analysis XPS 
 % N % C % H % N % C % O % Si 
LPMSN - 7.54 1.68 - 12.25 62.27 25.47 
A-MSN 1.05 6.99 1.59 1.33 13.62 59.18 25.87 
PDMAE-
LPMSN 
3.47 15.5 2.86 5.12 59.55 28.77 6.55 
 
 The details of surface modification occurred on the silica 
materials can be seen from the XPS analyses of N1s for A-MSN 
and PDMAEA-LPMSN (Fig. S4). Fig. S4A is a typical N1s 85 
spectrum for azide moiety. There are two peaks representing N+ 
species and N- species.28 After PDMAEA attachment, only one 
single peak of N1s is observed (Fig. S4B). This indicates that 
 
most of nitrogen atoms of azide groups have reacted with alkyne 
groups of PDMAEA. Thus only C-N binding from PDMAEA 
repeating unit can be detected. That is why only one single peak 
instead of two single peaks is observed. 
 Furthermore, we use 13C NMR analysis to confirm the 5 
successful attachment of PDMAEA and to reveal the molecular 
structure of PDMAEA-LPMSN. Fig. 3 shows the solid state 13C 
CP-MAS-NMR spectrum of PDMAEA-LPMSN. The peaks at 
9.5 ppm (C1) represent the covalent attachment of PDMAEA onto 
LPMSN through azide silane bridges. The peaks of C5, C* and C7 10 
confirm the successful binding between azide groups and alkyne 
groups of PDMAEA.29, 30 The chemical shifts of the 13C NMR 
resonances of the PDMAEA-LPMSN samples are compiled in 
Table 2. The chemical bindings can be revealed and attributed to 
the structure of PDMAEA. In addition, the introduction of 15 
PDMAEA produced positive charges on the silica surface, 
resulting in a positive PDMAEA-LPMSN potential value (+20 
mV as compared to LPMSN with -14.0 mV). 
 
 20 
 
Fig. 3 13C NMR of PDMAEA-LPMSN 
 
Table 2.  Summary of resonance of 13C CP NMR spectra for PDMAEA-
LPMSN 25 
PDMAEA-
LPMSN 
C1 C2 C3 C4 C5 C6 C7 
Chemical 
Shift (ppm) 
9.5 22.7 43.9 174.0 15.9 43.9 42.0 
PDMAEA-
LPMSN 
C8 C9 C10 C11 C12 C*  
Chemical 
Shift (ppm) 
38.0 176.3 70.5 57.7 43.9 111.3  
 
 Fig. S1 shows nitrogen sorption profile of LPMSN, A-MSN 
and PDMAEA-LPMSN. The azide attachment only gives minor 
effect on the surface area, pore volume and pore size. The values 
are similar to LPMSN. For both samples (LPMSN and A-MSN), 30 
the surface area were around 400 m2g, the pore volume at ~ 0.7 
cc/g and cavity size at around 11 nm (Table S1). However, the 
attachment of PDMAEA affected the physical properties. The 
BET surface area and pore volume values were reduced quite 
significantly to 105 m2/g and 0.32 cc/g. We propose that the high 35 
percentage of polymer (16% measured from TGA) grafted onto 
the pore surface and subsequent pore entrance blockage is 
responsible for such reduction. 
 We designed PDMAEA to be specifically attached on the 
MSN surface and not in the pores of MSN. This makes the 40 
internal pores which contain hydroxyl group to be accessible for 
drug molecules. For this reason, initially azide silane was grafted 
onto as-synthesized silica materials through sylilation reaction. 
The blocked pores of as-synthesized MSN ascertain azide 
moieties only attach on the external surface.31 After surfactant 45 
removal, azide-MSN (A-MSN) was connected to PDMAEA 
through a click reaction.29, 32 PDMAEA contains alkyne moieties 
which can chemically react with azide groups. The nitrogen 
sorption analysis (Fig. S1) confirms that the attachment of azide 
only occurs on the external surface and do not affect the pore 50 
volume or size of the original LPMSN. 
 To determine the binding and release of oligo DNA (mimic of 
siRNA) after conjugation with PDMAEA-LPMSN, we performed 
agarose gel retardation assay for PDMAEA-LPMSN at different 
incubation time (1 and 2 days). Fig. 4 shows the assay for 55 
PDMAEA-LPMSN and PEI-LPMSN at different N/P ratios (1 
and 10) to test the binding efficiency of the nanoparticles. For this 
experiment, we used two types of PDMAEA-LPMSN 
(PDMAEA-LPMSN and PDMAEA-LPMSN-X) with different 
concentrations. PDMAEA-LPMSN-X was designed to contain 60 
half of the PDMAEA compared to PDMAEA-LPMSN. As a 
comparison, we also synthesized a composite of 
polyethyleneimine (PEI) and LPMSN (PEI-LPMSN). PEI is 
known to be the most widely used polycationic for gene delivery 
and has been conjugated with MSN for similar purpose.8, 12  65 
 Fig. 4 Agarose gel retardation assay of PDMAEA-LPMSN and 
PEI-LPMSN after incubation for 30 minutes/Day-1 and after 
storage for 24 hours/Day-2. 
 5 
 As controls, we used oligo-DNA (lane-1) and LPMSN-oligo-
DNA (lane-2). It was expected that the unbound oligo-DNA 
which was released from the particles can be observed as an 
emerge band on specific lanes. This band will not be detected as 
long as the oligo-DNA bind to the nanoparticles.24 After 30 min 10 
incubation, a mark can be observed from incomplete binding of 
oligo-DNA with PDMAEA-LPMSN and PDMAEA-LPMSN X 
at N/P =1. In contrast, these marks were not detected in the case 
of PDMAEA-LPMSN and PDMAEA-LPMSN-X at N/P = 10. 
These results confirmed that higher N/P ratio is required for 15 
better interaction and complete binding of biomolecules. Larger 
N/P ratio causes a better condensation of complex of PDMAEA 
and oligo-DNA.23, 24 Thus, a complex of PDMAEA-LPMSN and 
oligo-DNA at N/P ratio of 10 performed strong interaction with 
oligo-DNA and maintained the complex stability.  20 
 The stable binding between carrier and oligo-DNA for the first 
several hours is very important to ascertain the delivery of the 
siRNA within the cytoplasm.23, 24 Interestingly, after 24 hours 
incubation, the smearing can be observed from most of the lane 
except from PEI-MSN. PEI is known to be very effective in 25 
performing complex with plasmid DNA and siRNA. The multiple 
amine moieties within PEI enable strong interaction with the 
nucleic acids and cell membrane. Yet, PEI also has some 
drawback regarding the release of the nucleic acid from the 
complexes.16, 17 The strong binding interaction between PEI and 30 
biomolecules hinders the release, thus no band is observed from 
PEI-MSN lane. In contrast, the smearing can be detected from all 
PDMAEA-LPMSN lanes. In the case of PDMAEA-LPMSN, 
PDMAEA is capable to maintain its ionic strength for the first 
few hours before starting to degrade to non-toxic compounds, 35 
leading to temporary binding of oligo-DNA. 23, 24 After released 
from PDMAEA-LPMSN, oligo-DNA can be observed in the gel, 
in agreement with previous reports. 23, 24 It was found that the 
polymer can maintain its binding with DNA for a sufficiently 
long period of time to transfect cells (around 4 hours) and then 40 
release the DNA inside the cells after 10 hours.23, 24  Therefore we 
choose the PDMAEA-LPMSN composition rather than 
conventional PEI functionalization in previous studies. 
 To enhance siRNA delivery, it is important for the carrier to 
escape from endosomal entrapment and deliver siRNA within 45 
cytoplasm. We introduced Chl in the LPMSN’s pores, which is 
also known as endosomal-escape inducing materials.14, 19. Chl is 
weakly basic and can be attracted with negatively charged silanol 
groups. It is very soluble in water with the solubility up to 1 
mg/ml.14, 33 However, the nature of PDMAEA-LPMSN that can 50 
be degraded in water makes the adsorption of Chl into 
PDMAEA-LPMSN in water impracticable. In addition, the 
nitrogen sorption shows that most of the entrance pores have been 
blocked after PDMAEA attachment, suggesting the adsorption of 
Chl after the polymer attachment is difficult. To optimize Chl 55 
adsorption, we designed the adsorption to be conducted after 
azide attachment (Scheme 1). Following surfactant removal, the 
pores of azide-MSN were accessible for Chl. The adsorption of 
Chl onto A-MSN was conducted in water for 24 hours.33 Then, 
PDMAEA attachment was carried in toluene. Loading amount of 60 
Chl in PDMAEA-LPMSN based on UV analysis was at 100 mg/g 
(0.1 mg/mg MSN). 
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Scheme 1. Detailed mechanism of chloroquine loading and siRNA binding for dual delivery 
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Fig. 5 Cytotoxicity test for PDMAEA-LPMSN and Chl-
PDMAEA-LPMSN 
 
 As shown in Scheme 1, PDMAEA-LPMSN is designed to co-
deliver siRNA and Chl in a controllable manner. After PDMAEA 10 
degradation, not only the siRNA can be released, but also the 
release of Chl is accelerated following the rupture of PDMAEA 
on the MSN surface, which promotes endosomal escapes of 
siRNA within cytoplasm. To evaluate the cytotoxicity of the 
composite materials (PDMAEA-LPMSN and Chl-PDMAEA-15 
LPMSN), we tested the effect of the particle’s concentration 
against KHOS cell viability. Fig. 5 shows that the composite 
materials induced negligible toxicity even at a very high 
concentration 400 µg/ml. The half maximal inhibitory 
concentration (IC50) values of PDMAEA-LPMSN and Chl-20 
PDMAEA-LPMSN were similar, around 1200 µg/ml, which can 
be explained by the very low toxicity of PDMAEA23, 24 and 
unmodified LPMSN.15  
 Similar to PDMAEA-LPMSN, Chl-PDMAEA-LPMSN did not 
affect the cell viability. This is in agreement with a previous 25 
report that showed Chl loaded MSN with a loading amount 0.15 
mg/mg (close to Chl-PDMAEA-LPMSN, 0.1 mg/mg) has 
negligible effect on cytotoxicity.14 Our findings confirm that both 
PDMAEA-LPMSN and Chl-PDMAEA-LPMSN are safe to be 
used even at a high concentration. 30 
 Fig. 6 illustrates the cell uptake study of PDMAEA-LPMSN 
and Chl-PDMAEA-LPMSN. Confocal microscopy was used to 
observe the internalization of the particles. At first, all particles 
were conjugated with oligo-DNA, and then incubated with 
KHOS cell lines. To adequately follow adsorption and the cell 35 
internalization process, oligo-DNA was labeled with cyanine dye 
(Cy3-oligo-DNA) to show red fluorescence. Cy3-oligo-DNA 
itself without any nano-carriers did not show any red signal 
coming from Cy3, similar as what observed in the control group 
without any treatment. The blue signals observed were from 40 
DAPI stained nuclei. In contrast, both PDMAEA-LPMSN and 
Chl-PDMAEA-LPMSN conjugated with Cy3-oligo-DNA reveal 
 
red signal. These results demonstrated that the negatively charged 
oligo-DNA themselves cannot enter into the cells, while the 
functional nanoparticles (PDMAEA-LPMSN and Chl-PDMAEA-
LPMSN) have the capacity to deliver the genetic molecules into 
the cells.   5 
 The polycation PDMAEA has the interaction with oligo-DNA 
and also cells membrane, essential for cellular uptake.8, 15 
Compared to PDMAEA-LPMSN, it was observed that Chl-
PDMAEA-LPMSN showed stronger and more homogeneous Cy3 
signal. It is known that Chl is a DNA intercalator which has 10 
preferential binding towards G-C sequence.34 We propose that 
Chl located adjacent to the external surface of LPMSN might 
improve the binding to oligo-DNA molecules. The stronger 
binding causes more oligo-DNA to be carried and delivered into 
the cells. After cellular uptake, Chl induce endosomal escape by 15 
its buffering capability.14 Consequently, the red signal coming 
from Cy3 is distributed homogeneously in the cytoplasm. In 
contrast, without Chl, the carriers are localised within discrete 
spot (see also Fig. 6).34  
 The ability of PDMAEA-LPMSN to co-deliver bio-functional 20 
siRNA and chloroquine (Chl) was investigated by using PLK1-
siRNA against polo-like kinase 1 and testing the cell toxicity in 
an osteosarcoma cell line KHOS. Fig. 7 confirms that PDMAEA-
LPMSN as a carrier has a negligible cell inhibition performance. 
Our previous study showed that PDMAEA as a single carrier has 25 
a low endosomal escape property,25 indicating that the siRNAs 
delivered by PDMAEA-LPMSN, similar to PDMAEA, cannot 
escape from endosomal entrapment to induce silencing effect.25 
In contrast, Chl-PDMAEA-LPMSN induces a reasonably 
significant decrease in cellular viability (25%). Our results have 30 
shown that although the actual benefit of PDMAEA as a single 
carrier for gene silencing is limited,25 the conjugation with 
LPMSN offers more opportunities for the fabrication of effective 
and multi-functional nano-carriers.  
  35 
 
Fig. 6  Assessments of cell uptake by confocal microscopy. The cell uptake efficiency of PDMAEA-LPMSN and Chl-PDMAEA-LPMSN were examined 
by labeling the particles with a 21-nt oligo DNA conjugated with Cy-3. 
 
 40 
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Fig.  7 Biological function analysis of PDMAEA-LPMSN and 
Chl-PDMAEA-LPMSN by delivering PLK1 siRNA in KHOS 
cells. 10 
Conclusion 
In this study, a novel gene carrier with selected properties: 
degradable, low toxicity and high capacity was prepared by 
grafting “self-catalyzed degradation” PDMAEA onto the surface 
of large pore and cubic mesostructured mesoporous silica 15 
nanoparticle to produce an efficient gene carrier: PDMAEA-
LPMSN. The composite materials have very low toxicity even at 
a very high concentration of 400 µg/ml. The degradable 
PDMAEA enables the release of siRNA after endocytosis. The 
chloroquine loaded inside the nanopores allows the cargo 20 
molecules escape from endosomal entrapment. These results 
demonstrate the potential of PDMAEA-LPMSN as a gene carrier. 
To fully use the potential of PDMAEA-LPMSN, it is expected 
that chemotherapy drugs can also be loaded, offering multi-
functional nano-carriers for dual delivery applications. 25 
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